Establishing the effectiveness of airway clearance techniques (ACTs) is vital for those involved in the management of patients with excessive secretions or with difficulty clearing secretions. The paper by Patterson et al. 1 aimed to compare the short-term effectiveness of a relatively new airway clearance technique of inspiratory resistance breathing called 'test of incremental respiratory endurance' (TIRE), with that of active cycle of breathing technique (ACBT) incorporating postural drainage and vibration in patients with noncystic fibrosis (CF) bronchiectasis. Contrary to a previous short-term study comparing these two techniques in patients with CF,2 Patterson et al. found that ACBT produced a significantly greater weight of sputum than TIRE.
The proposed mechanisms of action of these two interventions are different. ACBT incorporating postural drainage and vibration utilizes the theory of deep breathing with inspiratory hold to enhance collateral ventilation;3 postural drainage to assist with the movement of secretions centrally via gravity; vibration to loosen secretions (although this technique has not been examined in any detail);4 and forced expiration technique (FET) from low lung volume to provide increased linear velocity of flow more peripherally.5 TIRE, on the other hand, is aimed at the inspiratory phase of respiration and the proponents of the technique propose that it increases airflow to the more peripheral airways by extending inspiratory time due to breathing in against a fixed resistance.2 It is also possible that inspiring against an inspiratory resistance causes a greater negative pleural pressure that may dilate airways allowing more air behind mucus obstructions.6 This, in addition to the possibility that prolonged inspiration aids homogeneity of ventilation in diseased lung,7 may enhance secretion clearance.
Most previous ACTs have focused on the expiratory phase of respiration either as forced expiration techniques, or expiring through various positive expiratory pressure devices with or without oscillation. This is, in part, due to the fact that mucus transport by expiratory flow has been proposed as the primary mechanism by which patients with impaired mucociliary clearance move secretions centrally.8 Experimental evidence from in vitro9 and animals studies10 have shown that secretion clearance occurs by annular flow when expiratory flow rates (above a critical value) are greater than inspiratory flow rates, thus enhancing the two-phase gas-liquid flow in the expiratory direction. It may be of value in future studies of ACTs to evaluate the relationship between inspiratory and expiratory flow rates. Systematic reviews have concluded that ACTs increase mucus transport compared to no treatment or spontaneous cough in short term studies in CF1 1 and in COPD and bronchiectasis.12 However, the comparative efficacy of ACTs remains debatable. Systematic reviews and meta-analyses have been unable to find consistent differences between ACTs in terms oftheir enhancement ofmucociliary clearance in short-term studies.'2-14 One drawback of some clinical trials and reviews is that the results are pooled despite subjects having different pathology15 or disease severity.'3 This may negate the differences in efficacy ofvarious ACTs within subgroups or individuals. In such instances methods to evaluate individual patient improvement may be useful. '6 Evaluation of the efficacy of ACTs presents difficulties. Wet weight of expectorated sputum as used in the study by Patterson et al. 1 and also by many other researchers in evaluating the short term effectiveness of ACTs,2'17-20 may be affected by swallowed secretions and expectorated saliva. There is a poor correlation between expectorated sputum and measures of mucociliary clearance via radioactive tracer.18 The latter is more accepted as a reliable outcome measure in short-term studies but is only available in a few centres world-wide. 21 Other outcome measures used in ACT studies such as pulmonary function tests are likely to be insensitive in short-term studies.2'
Longer-term trials using outcome measures such as time to exacerbation, hospitalizations, lung function and quality of life may provide more clinically meaningful data on the efficacy of ACTs. Since shortterm studies do not allow adequate assessment of these outcome measures, future endeavours should include long-term randomized controlled trials. Concurrently, more work on the physiological effects of ACTs is required to substantiate proposed theoretical effects. The effects of ACTs on the rheology of mucus may provide additional support for use of some techniques.
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